Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 0.00%63.94M | -72.43%76.74M | 241.97%63.93M | 6.15%278.29M | -91.05%18.7M | 148.23%262.15M | 799.48%208.89M | -78.00%105.61M | -94.46%23.22M | 160.77%480.02M |
| Operating income | 0.00%63.94M | -72.43%76.74M | 241.97%63.93M | 6.15%278.29M | -91.05%18.7M | 148.23%262.15M | 799.48%208.89M | -78.00%105.61M | -94.46%23.22M | 160.77%480.02M |
| Cost of sales | -6.93%-59.62M | 71.07%-69.8M | -346.64%-55.76M | -35.13%-241.28M | 91.67%-12.48M | -174.85%-178.56M | -863.90%-149.8M | 79.80%-64.97M | 94.43%-15.54M | -156.45%-321.64M |
| Operating expenses | -6.93%-59.62M | 71.07%-69.8M | -346.64%-55.76M | -35.13%-241.28M | 91.67%-12.48M | -174.85%-178.56M | -863.90%-149.8M | 79.80%-64.97M | 94.43%-15.54M | -156.45%-321.64M |
| Gross profit | -47.25%4.31M | -81.26%6.94M | 31.62%8.18M | -55.73%37.01M | -89.49%6.21M | 105.68%83.59M | 669.16%59.09M | -74.34%40.64M | -94.50%7.68M | 169.99%158.39M |
| Selling expenses | 22.91%-1.81M | 57.80%-3.51M | 5.97%-2.35M | -13.27%-8.32M | 40.52%-2.5M | -39.77%-7.35M | -28.93%-4.2M | 36.05%-5.26M | -5.17%-3.26M | -32.06%-8.22M |
| Administrative expenses | 13.56%-5.69M | 12.07%-13.35M | 15.99%-6.58M | 27.41%-15.18M | 27.58%-7.84M | 3.35%-20.91M | -6.11%-10.82M | -15.01%-21.64M | -32.37%-10.2M | -16.59%-18.82M |
| Revaluation surplus | 88.96%-203K | -10,458.33%-11.19M | -29.44%-1.84M | 103.72%108K | 1.93%-1.42M | -129.04%-2.9M | -161.84%-1.45M | 25.82%-1.27M | -131.51%-553K | -132.31%-1.71M |
| -Changes in the fair value of investment property | 88.96%-203K | -10,458.33%-11.19M | -29.44%-1.84M | 103.72%108K | 1.93%-1.42M | -129.04%-2.9M | -161.84%-1.45M | 25.82%-1.27M | -131.51%-553K | -132.31%-1.71M |
| Impairment and provision | ---- | 164.44%476K | 220.62%622K | 103.30%180K | --194K | ---5.46M | ---- | ---- | ---- | 102.44%16K |
| -Impairment of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---5.04M | ---- | ---- | ---- | ---- |
| -Other impairment is provision | ---- | 164.44%476K | 220.62%622K | 142.15%180K | --194K | ---427K | ---- | ---- | ---- | 102.44%16K |
| Special items of operating profit | -18.39%1.47M | 53.69%3.43M | 25.00%1.8M | 298.14%2.23M | 179.03%1.44M | 79.71%-1.13M | -190.74%-1.82M | -174.17%-5.55M | -47.43%2.01M | -18.97%7.49M |
| Operating profit | -1,017.44%-1.92M | -207.39%-17.21M | 95.60%-172K | -65.05%16.02M | -109.58%-3.91M | 562.03%45.84M | 1,044.81%40.8M | -94.95%6.92M | -103.21%-4.32M | 173.35%137.14M |
| Financing cost | -250.00%-7K | 12.50%-7K | 66.67%-2K | 20.00%-8K | 25.00%-6K | 64.29%-10K | 57.89%-8K | 22.22%-28K | 44.12%-19K | -350.00%-36K |
| Earning before tax | -1,008.62%-1.93M | -207.49%-17.21M | 95.55%-174K | -65.06%16.01M | -109.60%-3.91M | 564.57%45.83M | 1,040.49%40.79M | -94.97%6.9M | -103.23%-4.34M | 173.32%137.11M |
| Tax | 78.68%-776K | -186.10%-24.1M | -802.70%-3.64M | 38.08%-8.42M | 103.78%518K | -85.15%-13.6M | -1,018.94%-13.71M | 80.75%-7.35M | 96.40%-1.23M | -132.33%-38.16M |
| After-tax profit from continuing operations | 29.08%-2.71M | -644.27%-41.31M | -12.31%-3.81M | -76.45%7.59M | -112.54%-3.4M | 7,245.45%32.23M | 586.91%27.08M | -100.46%-451K | -105.55%-5.56M | 193.27%98.95M |
| Earning after tax | 29.08%-2.71M | -644.27%-41.31M | -12.31%-3.81M | -76.45%7.59M | -112.54%-3.4M | 7,245.45%32.23M | 586.91%27.08M | -100.46%-451K | -105.55%-5.56M | 193.27%98.95M |
| Minority profit | -1,675.00%-252K | -123.35%-720K | 133.33%16K | 240.66%3.08M | 90.84%-48K | 151.60%905K | 60.87%-524K | -2,884.13%-1.75M | -200.53%-1.34M | -89.41%63K |
| Profit attributable to shareholders | 35.95%-2.45M | -1,000.60%-40.59M | -14.40%-3.83M | -85.61%4.51M | -112.13%-3.35M | 2,303.76%31.32M | 753.71%27.61M | -98.68%1.3M | -104.27%-4.22M | 198.35%98.88M |
| Basic earnings per share | 42.86%-0.0004 | -975.00%-0.007 | -16.67%-0.0007 | -85.19%0.0008 | -112.77%-0.0006 | 2,600.00%0.0054 | 771.43%0.0047 | -98.82%0.0002 | -104.12%-0.0007 | 196.49%0.0169 |
| Diluted earnings per share | 42.86%-0.0004 | -975.00%-0.007 | -16.67%-0.0007 | -85.19%0.0008 | -112.77%-0.0006 | 2,600.00%0.0054 | 0.0047 | 0.0002 | ||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.